{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:42:47Z","timestamp":1773409367479,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA 27469"],"award-info":[{"award-number":["CA 27469"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA 11479"],"award-info":[{"award-number":["CA 11479"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA 37517"],"award-info":[{"award-number":["CA 37517"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ygyno.2011.12.414","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T01:08:45Z","timestamp":1323392925000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: A Gynecologic Oncology Group study"],"prefix":"10.1016","volume":"125","author":[{"given":"Krishnansu S.","family":"Tewari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia L.","family":"Filiaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick M.","family":"Spirtos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Mannel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Tate","family":"Thigpen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Cibull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley J.","family":"Monk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus E.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.12.414_bb0185","first-page":"212","article-title":"The impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"218","key":"10.1016\/j.ygyno.2011.12.414_bb0190","first-page":"e1","article-title":"Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths","volume":"198","author":"Ueda","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0195","first-page":"105","article-title":"Revised FIGO staging for carcinoma of the endometrium","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4 Suppl","key":"10.1016\/j.ygyno.2011.12.414_bb0205","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/cncr.2820710409","article-title":"International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988","volume":"71","author":"Mikuta","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression model and life tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0045","series-title":"Handbook of statistics in clinical oncology","first-page":"525","article-title":"Meta-analysis","author":"Duchateau","year":"2001"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P","article-title":"Tutorial in biostatistics meta-analysis: formulating, evaluating, combining, and reporting","volume":"18","author":"Normand","year":"1999","journal-title":"Stat Med"},{"issue":"21","key":"10.1016\/j.ygyno.2011.12.414_bb0055","first-page":"91","article-title":"Radiation therapy and combined chemo-irradiation in advanced and recurrent endometrial carcinoma","volume":"1004","author":"Randall","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0060","first-page":"21","article-title":"Phase II trial of Adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"63","author":"Thigpen","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0090-8258(89)90605-7","article-title":"Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study","volume":"33","author":"Thigpen","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.1994.12.7.1408","article-title":"A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"12","author":"Thigpen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0075","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","article-title":"Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"22","author":"Thigpen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mdg112","article-title":"Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group","volume":"14","author":"Aapro","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0090","unstructured":"Miller DS (study chair). GOG protocol 209: a randomized phase III trial of doxorubicin\/cisplatin\/paclitaxel and G-CSF versus carboplatin\/paclitaxel in patients with stage III & IV or recurrent endometrial cancer. http:\/\/www.cancer.gov\/search\/ViewClinicalTrials.aspx?cdrid=305940&version=HealthProfessional&protocolsearchid=8603435"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0095","unstructured":"Matei D (study chair). GOG protocol 258: a randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. http:\/\/www.cancer.gov\/search\/ViewClinicalTrials.aspx?cdrid=649079&version=HealthProfessional&protocolsearchid=7990461"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","article-title":"A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a Gynecologic Oncology Group study","volume":"112","author":"Homesley","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2009.06.035","article-title":"Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation","volume":"115","author":"Klopp","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/gyno.1999.5569","article-title":"FIGO stage III endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant RT","volume":"75","author":"Nelson","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0115","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0360-3016(91)90744-O","article-title":"Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma","volume":"21","author":"Gibbons","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0360-3016(00)00724-0","article-title":"Treatment of high-risk uterine cancer with whole abdominopelvic RT","volume":"48","author":"Smith","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0210","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/bjc.1997.313","article-title":"Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy","volume":"5","author":"Onda","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","article-title":"Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology","volume":"102","author":"Lutman","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ygyno.2005.12.010","article-title":"Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer","volume":"102","author":"Takeshima","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0140","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ijgc-00009577-200309000-00015","article-title":"FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival","volume":"13","author":"Bristow","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0145","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2005.07.014","article-title":"Resection of lymph node metastases influences survival in stage IIIC endometrial cancer","volume":"99","author":"Havrilesky","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11864-003-0013-z","article-title":"Endometrial cancer: treatment of nodal metastases","volume":"4","author":"McMeekin","year":"2003","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0155","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1067\/mob.2001.115225","article-title":"Survival after multimodality treatment for stage IIIC endometrial cancer","volume":"184","author":"Katz","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0160","first-page":"1083","article-title":"Postoperative adjuvant chemotherapy with cisplatin, etoposide, and pirarubicin for endometrial carcinoma patients with lymph node metastasis: a pilot study","volume":"7","author":"Umesaki","year":"2000","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0165","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2009.03.007","article-title":"Stage II endometrioid adenocarcinoma of the endometrium. Clinical implications of cervical stromal invasion","volume":"113","author":"Orezzoli","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2009.07.005","article-title":"Adjuvant radiation therapy in stage III node-positive uterine cancer","volume":"115","author":"Schmid","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/jnci\/djk106","article-title":"Association versus causation versus quality improvement: setting benchmarks for lymph node evaluation in colon cancer","volume":"99","author":"Ricciardi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.12.414_bb0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.2006.09.2304","article-title":"Quality of pathology reporting impacts on lymph node yield in colon cancer","volume":"25","author":"Rieger","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811013874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811013874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:30:35Z","timestamp":1758771035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811013874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0090825811013874"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.12.414","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: A Gynecologic Oncology Group study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.12.414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}